HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rui Sun Selected Research

antagomir-429

9/2020[Inhibitory effect of miR-429 on expressions of ZO-1, Occludin, and Claudin-5 proteins to improve the permeability of blood spinal cord barrier in vitro].
12/2018MiR-429 improved the hypoxia tolerance of human amniotic cells by targeting HIF-1α.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rui Sun Research Topics

Disease

208Neoplasms (Cancer)
04/2024 - 01/2003
87Nasopharyngeal Carcinoma
01/2024 - 04/2004
53Neoplasm Metastasis (Metastasis)
01/2024 - 01/2003
46Infections
05/2024 - 11/2004
29Inflammation (Inflammations)
03/2024 - 09/2006
21Hepatocellular Carcinoma (Hepatoma)
12/2023 - 05/2004
19Breast Neoplasms (Breast Cancer)
02/2024 - 01/2013
18Hepatitis
01/2019 - 09/2003
15Lung Neoplasms (Lung Cancer)
04/2024 - 09/2003
15Carcinogenesis
10/2023 - 09/2005
12Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2023 - 01/2017
12Leukemia
01/2022 - 10/2005
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 09/2005
11Necrosis
11/2023 - 08/2004
10Prostatic Neoplasms (Prostate Cancer)
01/2024 - 11/2019
10COVID-19
10/2023 - 01/2020
9Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 07/2006
9Lymphoma (Lymphomas)
01/2023 - 07/2015
9Hypoxia (Hypoxemia)
01/2023 - 04/2014
9Virus Diseases (Viral Diseases)
01/2020 - 11/2004
8Type 2 Diabetes Mellitus (MODY)
05/2024 - 10/2017
8Wounds and Injuries (Trauma)
01/2024 - 01/2021
8Body Weight (Weight, Body)
08/2023 - 04/2006
7Neuroinflammatory Diseases
03/2024 - 01/2022
7Brain Ischemia (Cerebral Ischemia)
03/2024 - 01/2018
7Carcinoma (Carcinomatosis)
11/2023 - 12/2013
7Stomach Neoplasms (Stomach Cancer)
09/2023 - 08/2014
7Colonic Neoplasms (Colon Cancer)
01/2023 - 02/2005
7Lymphatic Metastasis
01/2023 - 09/2005
7Liver Diseases (Liver Disease)
01/2022 - 05/2004
7Chronic Hepatitis B
11/2021 - 09/2007
7Massive Hepatic Necrosis
05/2014 - 11/2005
6Reperfusion Injury
03/2024 - 01/2018
6Adenocarcinoma
01/2024 - 02/2005
6Melanoma (Melanoma, Malignant)
07/2023 - 10/2015
5Residual Neoplasm
05/2024 - 12/2014
5Squamous Cell Carcinoma of Head and Neck
04/2024 - 07/2011
5Rupture
04/2024 - 09/2018
5Alzheimer Disease (Alzheimer's Disease)
03/2024 - 02/2019
5Hematologic Neoplasms (Hematological Malignancy)
02/2024 - 06/2020
5Atherosclerosis
02/2024 - 01/2016
5Cognitive Dysfunction
01/2024 - 03/2013
5Fibrosis (Cirrhosis)
01/2023 - 10/2006
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2023 - 01/2020
5Neutropenia
01/2023 - 09/2013
5Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2022 - 10/2006

Drug/Important Bio-Agent (IBA)

71Proteins (Proteins, Gene)FDA Link
03/2024 - 05/2004
35CytokinesIBA
03/2024 - 09/2003
27Biomarkers (Surrogate Marker)IBA
01/2024 - 12/2013
27DNA (Deoxyribonucleic Acid)IBA
01/2024 - 03/2013
25LigandsIBA
04/2024 - 11/2004
23Cisplatin (Platino)FDA LinkGeneric
04/2024 - 09/2013
20Messenger RNA (mRNA)IBA
01/2024 - 05/2004
18RNA (Ribonucleic Acid)IBA
12/2023 - 10/2008
16MicroRNAs (MicroRNA)IBA
10/2023 - 02/2012
15Poly I-CIBA
01/2019 - 11/2004
14Therapeutic UsesIBA
01/2024 - 10/2008
13Chimeric Antigen ReceptorsIBA
01/2024 - 04/2018
10Reactive Oxygen Species (Oxygen Radicals)IBA
03/2024 - 07/2015
10AntigensIBA
01/2024 - 01/2015
10LipidsIBA
10/2023 - 08/2014
9Fluorouracil (Carac)FDA LinkGeneric
01/2023 - 04/2004
9Concanavalin AIBA
03/2014 - 05/2004
8ChemokinesIBA
04/2024 - 08/2004
8Immunoglobulin G (IgG)IBA
04/2024 - 12/2012
8Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 12/2005
7Doxorubicin (Adriamycin)FDA LinkGeneric
02/2024 - 07/2020
7Peptides (Polypeptides)IBA
01/2024 - 07/2012
7EnzymesIBA
01/2024 - 03/2015
7InterferonsIBA
11/2023 - 09/2012
7ErbB Receptors (EGF Receptor)IBA
05/2023 - 10/2018
7AntibodiesIBA
01/2023 - 01/2015
7AntioxidantsIBA
05/2022 - 01/2018
6Matrix Metalloproteinases (MMPs)IBA
02/2024 - 12/2010
6Androgen Receptors (Androgen Receptor)IBA
10/2023 - 09/2017
6Tyrosine Kinase InhibitorsIBA
05/2023 - 09/2017
6Small Interfering RNA (siRNA)IBA
03/2023 - 06/2015
6Interleukin-6 (Interleukin 6)IBA
02/2023 - 05/2004
6Ethanol (Ethyl Alcohol)IBA
01/2022 - 08/2004
6Histones (Histone)IBA
01/2022 - 01/2019
6Interleukin-12 (IL 12)IBA
11/2020 - 02/2012
6Interferon-gamma (Interferon, gamma)IBA
01/2019 - 05/2005
5ProteomeIBA
04/2024 - 11/2019
5PolymersIBA
02/2024 - 11/2014
5Liposomes (Liposome)IBA
02/2024 - 03/2009
5GemcitabineFDA Link
06/2023 - 01/2019
56-methyladenineIBA
01/2023 - 01/2021
5Transcription Factors (Transcription Factor)IBA
01/2023 - 01/2016

Therapy/Procedure

94Therapeutics
03/2024 - 01/2011
45Radiotherapy
05/2024 - 04/2004
40Drug Therapy (Chemotherapy)
02/2024 - 10/2008
29Chemoradiotherapy
01/2024 - 10/2009
29Immunotherapy
01/2024 - 02/2004
19Induction Chemotherapy
12/2023 - 10/2009
14Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2023 - 05/2013
10Precision Medicine
03/2024 - 05/2016
8Lasers (Laser)
11/2023 - 05/2005
8Photothermal Therapy
11/2023 - 02/2017
6Neoadjuvant Therapy
01/2024 - 09/2013
5Hematopoietic Stem Cell Transplantation
08/2023 - 01/2020